Cargando…

Pre-pregnancy body mass index and the risk of adverse outcome in type 1 diabetic pregnancies: a population-based cohort study

OBJECTIVE: To assess the risk of perinatal complications in overweight and obese women with and without type 1 diabetes (T1DM). DESIGN: Prospective population-based cohort study. SETTING: This study was based on data from the Swedish Medical Birth Registry from 1998 to 2007. PARTICIPANTS: 3457 T1DM...

Descripción completa

Detalles Bibliográficos
Autores principales: Persson, Martina, Pasupathy, Dharmintra, Hanson, Ulf, Westgren, Magnus, Norman, Mikael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Group 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282288/
https://www.ncbi.nlm.nih.gov/pubmed/22334581
http://dx.doi.org/10.1136/bmjopen-2011-000601
_version_ 1782224062077992960
author Persson, Martina
Pasupathy, Dharmintra
Hanson, Ulf
Westgren, Magnus
Norman, Mikael
author_facet Persson, Martina
Pasupathy, Dharmintra
Hanson, Ulf
Westgren, Magnus
Norman, Mikael
author_sort Persson, Martina
collection PubMed
description OBJECTIVE: To assess the risk of perinatal complications in overweight and obese women with and without type 1 diabetes (T1DM). DESIGN: Prospective population-based cohort study. SETTING: This study was based on data from the Swedish Medical Birth Registry from 1998 to 2007. PARTICIPANTS: 3457 T1DM and 764 498 non-diabetic pregnancies were included. T1DM was identified based on ICD code O24.0. Mothers were categorised according to pre-pregnancy body mass index (BMI: weight in kilograms per height in square metres) as normal weight (BMI 18.5–24.9), overweight (BMI 25–29.9) or obese (BMI ≥30). Only women with singleton pregnancies and with data on BMI were included. PRIMARY/SECONDARY OUTCOMES: The primary outcome was large for gestational age (LGA: birth weight >90th percentile) infants. Secondary outcomes were major malformations, pre-eclampsia (PE), preterm delivery, perinatal mortality, delivery by Caesarean section and neonatal overweight. Logistic regression analysis was performed with normal weight non-diabetic women as the reference category and also within the diabetic cohort with normal weight type 1 diabetic women as the reference. The ORs were adjusted for ethnicity, maternal age, height, parity, smoking and chronic hypertension. RESULTS: 35% of women with T1DM were overweight and 18% were obese, as compared with 26% and 11%, respectively, in non-diabetic pregnancies. The incidences of adverse outcome increased with greater BMI category. As compared with non-diabetic normal weight women, the adjusted OR for obese T1DM for LGA was 13.26 (95% CI 11.27 to 15.59), major malformations 4.11 (95% CI 2.99 to 5.65) and PE 14.19 (95% CI 11.50 to 17.50). T1DM was a significant effect modifier of the association between BMI and LGA, major malformations and PE (p<0.001). CONCLUSION: High pre-pregnancy BMI is an important risk factor for adverse outcome in type 1 diabetic pregnancies. The combined effect of both T1DM and overweight or obesity constitutes the greatest risk. It seems prudent to strive towards normal pre-pregnancy BMI in women with T1DM.
format Online
Article
Text
id pubmed-3282288
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BMJ Group
record_format MEDLINE/PubMed
spelling pubmed-32822882012-02-22 Pre-pregnancy body mass index and the risk of adverse outcome in type 1 diabetic pregnancies: a population-based cohort study Persson, Martina Pasupathy, Dharmintra Hanson, Ulf Westgren, Magnus Norman, Mikael BMJ Open Diabetes and Endocrinology OBJECTIVE: To assess the risk of perinatal complications in overweight and obese women with and without type 1 diabetes (T1DM). DESIGN: Prospective population-based cohort study. SETTING: This study was based on data from the Swedish Medical Birth Registry from 1998 to 2007. PARTICIPANTS: 3457 T1DM and 764 498 non-diabetic pregnancies were included. T1DM was identified based on ICD code O24.0. Mothers were categorised according to pre-pregnancy body mass index (BMI: weight in kilograms per height in square metres) as normal weight (BMI 18.5–24.9), overweight (BMI 25–29.9) or obese (BMI ≥30). Only women with singleton pregnancies and with data on BMI were included. PRIMARY/SECONDARY OUTCOMES: The primary outcome was large for gestational age (LGA: birth weight >90th percentile) infants. Secondary outcomes were major malformations, pre-eclampsia (PE), preterm delivery, perinatal mortality, delivery by Caesarean section and neonatal overweight. Logistic regression analysis was performed with normal weight non-diabetic women as the reference category and also within the diabetic cohort with normal weight type 1 diabetic women as the reference. The ORs were adjusted for ethnicity, maternal age, height, parity, smoking and chronic hypertension. RESULTS: 35% of women with T1DM were overweight and 18% were obese, as compared with 26% and 11%, respectively, in non-diabetic pregnancies. The incidences of adverse outcome increased with greater BMI category. As compared with non-diabetic normal weight women, the adjusted OR for obese T1DM for LGA was 13.26 (95% CI 11.27 to 15.59), major malformations 4.11 (95% CI 2.99 to 5.65) and PE 14.19 (95% CI 11.50 to 17.50). T1DM was a significant effect modifier of the association between BMI and LGA, major malformations and PE (p<0.001). CONCLUSION: High pre-pregnancy BMI is an important risk factor for adverse outcome in type 1 diabetic pregnancies. The combined effect of both T1DM and overweight or obesity constitutes the greatest risk. It seems prudent to strive towards normal pre-pregnancy BMI in women with T1DM. BMJ Group 2012-02-14 /pmc/articles/PMC3282288/ /pubmed/22334581 http://dx.doi.org/10.1136/bmjopen-2011-000601 Text en © 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.
spellingShingle Diabetes and Endocrinology
Persson, Martina
Pasupathy, Dharmintra
Hanson, Ulf
Westgren, Magnus
Norman, Mikael
Pre-pregnancy body mass index and the risk of adverse outcome in type 1 diabetic pregnancies: a population-based cohort study
title Pre-pregnancy body mass index and the risk of adverse outcome in type 1 diabetic pregnancies: a population-based cohort study
title_full Pre-pregnancy body mass index and the risk of adverse outcome in type 1 diabetic pregnancies: a population-based cohort study
title_fullStr Pre-pregnancy body mass index and the risk of adverse outcome in type 1 diabetic pregnancies: a population-based cohort study
title_full_unstemmed Pre-pregnancy body mass index and the risk of adverse outcome in type 1 diabetic pregnancies: a population-based cohort study
title_short Pre-pregnancy body mass index and the risk of adverse outcome in type 1 diabetic pregnancies: a population-based cohort study
title_sort pre-pregnancy body mass index and the risk of adverse outcome in type 1 diabetic pregnancies: a population-based cohort study
topic Diabetes and Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282288/
https://www.ncbi.nlm.nih.gov/pubmed/22334581
http://dx.doi.org/10.1136/bmjopen-2011-000601
work_keys_str_mv AT perssonmartina prepregnancybodymassindexandtheriskofadverseoutcomeintype1diabeticpregnanciesapopulationbasedcohortstudy
AT pasupathydharmintra prepregnancybodymassindexandtheriskofadverseoutcomeintype1diabeticpregnanciesapopulationbasedcohortstudy
AT hansonulf prepregnancybodymassindexandtheriskofadverseoutcomeintype1diabeticpregnanciesapopulationbasedcohortstudy
AT westgrenmagnus prepregnancybodymassindexandtheriskofadverseoutcomeintype1diabeticpregnanciesapopulationbasedcohortstudy
AT normanmikael prepregnancybodymassindexandtheriskofadverseoutcomeintype1diabeticpregnanciesapopulationbasedcohortstudy